Skip to content
BioRegenis — home

BioChip Skin

Progress

49%

Current phase

Phase I

p2

  1. Preclinical
  2. Phase I
  3. Phase II
  4. Phase III
  5. Phase IV

The development phases

These are the standard phases of pharmaceutical development: preclinical work precedes testing in humans, phases I to III test the product in progressively larger groups, and phase IV follows it after authorisation. The percentage states how far the programme has declared itself along that path.

  1. Preclinical0–25%
  2. Phase I26–50%
  3. Phase II51–75%
  4. Phase III76–90%
  5. Phase IV91–100%
  6. The five phases indicate each programme's internal development status, from initial research through to market.

Other programmes

Back to pipeline